Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;8(6):386-393.
doi: 10.1016/j.jpha.2017.09.004. Epub 2017 Sep 25.

Long-term stability of gentamicin sulfate-ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) solution for catheter locks

Affiliations

Long-term stability of gentamicin sulfate-ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) solution for catheter locks

Anne-Sophie Fiolet et al. J Pharm Anal. 2018 Dec.

Abstract

A lock solution composed of gentamicin sulfate (5 mg/mL) and ethylenediaminetetraacetic acid disodium salt (EDTA-Na2, 30 mg/mL) could fully eradicate in vivo bacterial biofilms in totally implantable venous access ports (TIVAP). In this study, fabrication, conditioning and sterilization processes of antimicrobial lock solution (ALS) were detailed and completed by a stability study. Stability of ALS was conducted for 12 months in vial (25 °C ± 2 °C, 60% ± 5% relative humidity (RH), and at 40 °C ± 2 °C, RH 75% ± 5%) and for 24 h and 72 h in TIVAP (40 °C ± 2 °C, RH 75% ± 5%). A stability indicating HPLC assay with UV detection for simultaneous quantification of gentamicin sulfate and EDTA-Na2 was developed. ALS was assayed by ion-pairing high performance liquid chromatography (HPLC) needing gentamicin derivatization, EDTA-Na2 metallocomplexation of samples and gradient mobile phase. HPLC methods to separate four gentamicin components and EDTA-Na2 were validated. Efficiency of sterility procedure and conditioning of ALS was confirmed by bacterial endotoxins and sterility tests. Physicochemical stability of ALS was determined by visual inspection, osmolality, pH, and sub-visible particle counting. Results confirmed that the stability of ALS in vials was maintained for 12 months and 24 h and 72 h in TIVAP.

Keywords: Gentamicin-EDTA-Na2 loaded antimicrobial lock solution; Pharmaceutical compounding; Stability indicating HPLC assay method; Totally implantable venous access ports.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) A typical chromatogram of gentamicin standard solution (USP) (216 µg/mL) after OPA derivatization. (B) A typical chromatogram of sisomicin after OPA derivatization (4.65 mg/mL). (C) A typical chromatogram of ALS after OPA derivatization (gentamicin 217 µg/mL). (D) Analysis of ALS (gentamicin 217 µg/mL) under oxidative conditions (3% H2O2, 80 °C for 3 h) after OPA derivatization.
Fig. 2
Fig. 2
(A) A typical chromatogram of EDTA-Na2 (USP) (1.3 mg/mL) after CuSO4 complexation. (B) A typical chromatogram of nitrilotriacetic acid (43 µg/mL) after CuSO4 complexation. (C) A typical chromatogram of ALS (EDTA-Na2: 1.3 mg/mL) after CuSO4 complexation. (D) Analysis of ALS (EDTA-Na2: 1.3 mg/mL) under stress oxidative conditions (3% H2O2, 80 °C for 3 h) after CuSO4 complexation.
Fig. 3
Fig. 3
(A) A typical calibration curve of the cumulative peak area (C1, C1a, C2a, C2) of gentamicin sulfate (Panpharma®) (a) and four components (b, c, d and e) ranged from 87 to 260 µg/mL. (B) A typical EDTA-Na2 calibration curve ranged from 0.52 to 1.56 mg/mL.
Fig. 4
Fig. 4
Linear relationship between water loss through TIVAP and time of storage at 40 °C ± 2 °C, RH 75% ± 5%.

Similar articles

Cited by

References

    1. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis. 2007;7:645–657. - PubMed
    1. Beloin C., Fernández-Hidalgo N., Lebeaux D. Understanding biofilm formation in intravascular device-related infections. Intensive Care Med. 2017;43:443–446. - PubMed
    1. Bookstaver P.B., Rokas K.E.E., Norris L.B. Vol. 70. 2013. Stability and compatibility of antimicrobial lock solutions; pp. 2185–2198. (Am. J. Health-Syst. Pharm. AJHP Off. J. Am. Soc. Health-Syst. Pharm.). - PubMed
    1. Hogan S., Zapotoczna M., Stevens N.T. In vitro approach for identification of the most effective agents for antimicrobial lock therapy in the treatment of intravascular catheter-related infections caused by Staphylococcus aureus. Antimicrob. Agents Chemother. 2016;60:2923–2931. - PMC - PubMed
    1. Mermel L.A., Allon M., Bouza E. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2009;49:1–45. - PMC - PubMed

LinkOut - more resources